{
    "Case ID": "005239",
    "Crime_Name": [
        "Patent Infringement Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Infringement"
    ],
    "Legal_Issue": [
        "Validity of the '967 patent",
        "Anticipation",
        "Obviousness",
        "Lack of utility",
        "Insufficiency of disclosure",
        "Overbroad claims"
    ],
    "Governing_Law": [
        "Canadian Patent Law"
    ],
    "Procedural_Stage": [
        "Application under NOC Regulations"
    ],
    "Evidence_Assessment": [
        "Prior art (WO371) disclosed similar particle sizes",
        "Common general knowledge included dosage ranges",
        "Utility claims lacked substantiation",
        "'About' in claims was narrowly interpreted"
    ],
    "Decision_Outcome": [
        "'967 patent found invalid",
        "Application to prohibit Apotex dismissed"
    ],
    "Burden_of_Proof": [
        "Balance of probabilities"
    ],
    "Credibility_Factor": [
        "Expert testimonies and affidavits evaluated"
    ],
    "Legal_Rule": [
        "A patent must be novel, non-obvious, useful, and sufficiently disclosed"
    ],
    "Standard_of_Review": [
        "Balance of probabilities"
    ],
    "Procedural_Issue": [
        "NOC proceeding to block generic drug launch"
    ],
    "Grounds_for_Claim": [
        "Anticipation",
        "Obviousness",
        "Lack of utility",
        "Insufficiency",
        "Overbreadth"
    ],
    "Outcome_on_Merits": [
        "Patent invalid on grounds of anticipation, obviousness, and lack of utility"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Not applicable â€“ first instance decision"
    ],
    "Review_Standard": [
        "Balance of probabilities"
    ],
    "Procedural_Fairness_Assessment": [
        "Full hearing with expert evidence and submissions"
    ],
    "Key_Evidence_Considered": [
        "WO371 prior art",
        "Expert testimony",
        "Affidavits",
        "Claim language including 'about'"
    ],
    "Legal_Framework": [
        "Patent Act (Canada)",
        "Notice of Compliance (NOC) Regulations"
    ],
    "Applicant_Challenge": [
        "Cephalon sought prohibition of Apotex's generic product"
    ],
    "Court_Result": [
        "Dismissed Cephalon's application"
    ],
    "Legal_Rule_Source": [
        "Canadian Patent Law"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Apotex challenged validity of '967 patent on multiple grounds"
    ],
    "Evidence_Type": [
        "Documentary evidence",
        "Expert evidence",
        "Affidavit evidence"
    ],
    "Remedy_Requested": [
        "Order to prevent Apotex from marketing generic modafinil"
    ],
    "Outcome": [
        "Cephalon unsuccessful; Apotex allowed to proceed"
    ],
    "Decision_Authority": [
        "Federal Court (implied by NOC context)"
    ],
    "Remedy_Sought": [
        "Interim injunction via NOC proceedings"
    ],
    "Resolution_Mechanism": [
        "Judicial determination on patent validity"
    ],
    "Legal_Provision": [
        "Section 6 of the NOC Regulations",
        "Patent Act"
    ],
    "Authority": [
        "Canadian courts"
    ],
    "Claimant_Status": [
        "Patent holder (Cephalon)"
    ],
    "Legal_Provision_Cited": [
        "Patent Act",
        "NOC Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Invalidity due to anticipation, obviousness, lack of utility, insufficiency, overbreadth"
    ],
    "Applicable_Process": [
        "NOC litigation process"
    ],
    "Outcome_of_Review": [
        "Patent declared invalid"
    ],
    "Pending_Relief_or_Application": [
        "Application to prohibit market entry"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Canadian Patent Law requirements for novelty, non-obviousness, utility, and sufficiency"
    ]
}